Monotherapy with atazanavir as a simplification strategy: results from an observational study.
Francesca
F
Cossarini
Stefania
S
Salpietro
Laura
L
Galli
Nicola
N
Gianotti
Silvia
S
Nozza
Vincenzo
V
Spagnuolo
Hamid
H
Hasson
Simona
S
Bossolasco
Adriano
A
Lazzarin
Giuseppe
G
Tambussi
Antonella
A
Castagna
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D018791:CD4 Lymphocyte Count; D016516:CD4-CD8 Ratio; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D017211:Treatment Failure
D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D012367:RNA, Viral; D000069446:Atazanavir Sulfate